AI/ML in Drug Discovery 101: Understanding Applications, Roadblocks & Collaboration Opportunities to Leverage In Silico Tools for Best-in-Class Drug Discovery & Development

9:30 am - Tuesday 8th December 2026

AI has truly become the buzzword as the tool to improve the quality of, and accelerate, drug discovery timelines. But how impactful are AI/ML discovery tools, and what has been proven experimentally so far to demonstrate reliability?

Join this workshop to break down the applications and bottlenecks of AI/ML for de novo discovery, and learn how best to blend in silico and wet lab expertise.

Workshop Highlights Include:

  • Seeing through the AI hype: Breaking down different augmentations of AI/ML tools to improve the quality and reduce cost and timelines of drug discovery workflows
  • Understanding what has been shown to be effective so far through experimental validation, and what areas remain challenging – what are the core hesitancies to adopt AI/ML discovery tools? 
  • Limits and and failures of structure prediction tools: Understanding methods to steer AI/ML models to generate transition-state conformations without further training
  • Integrating wet lab and computational insights to unlock mutual benefit towards best-in-class drugs

Speakers:

Assistant Professor
Seoul National University
Founder & Chief Executive Officer
AIGEN Sciences
Research Associate
Korea University